PWS
PRPH

Precision Wealth Strategies’s ProPhase Labs PRPH Stock Holding History

Precision Wealth Strategies’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,239
Closed -$90K – 102
2023
Q2 		$90K Sell
1,239
-128
-9% -$10.4K 0.15% 62
2023
Q1 		$104K Buy
1,367
+361
+36% +$29.1K 0.16% 70
2022
Q4 		$96.9K Sell
1,006
-50
-5% -$5.4K 0.1% 103
2022
Q3 		$109K Buy
1,056
+6
+0.6% +$698 0.1% 124
2022
Q2 		$152K Buy
+1,050
New +$92.3K 0.12% 140

Other funds holding PRPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

Precision Wealth Strategies's PRPH Position: Q3 2023 in Review

Precision Wealth Strategies sold out of ProPhase Labs (PRPH) in Q3 2023, closing a stake of 1,239 shares — an estimated $90K sold.

Precision Wealth Strategies first reported a position in PRPH in Q2 2022 and held it in 5 quarters. The position peaked at $152K in Q2 2022. 35 funds tracked by Wall St. Rank hold PRPH as of Q3 2023.

  • Precision Wealth Strategies reported no remaining ProPhase Labs position as of Q3 2023 after selling out during the quarter.
  • Precision Wealth Strategies sold 1,239 ProPhase Labs shares in Q3 2023, an estimated $90K.
  • Precision Wealth Strategies first reported a position in ProPhase Labs in Q2 2022 and held it in 5 quarters.
  • Precision Wealth Strategies's ProPhase Labs position peaked at $152K in Q2 2022.
  • 35 funds tracked by Wall St. Rank held ProPhase Labs as of Q3 2023.

Based on Precision Wealth Strategies's 13F filing for Q3 2023, filed 31 Oct 2023.